Cellectis
CLLS
#9412
Rank
โ‚ฌ0.13 B
Marketcap
1,32ย โ‚ฌ
Share price
-1.31%
Change (1 day)
-57.66%
Change (1 year)

Cellectis (CLLS) Fails to deliver data

Key failure to deliver metrics for Cellectis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Cellectis (CLLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Cellectis (CLLS) - since 2015

Volume in USD (price x number of shares), data since 2015

Cellectis (CLLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚ฌ0.22 M-38.81%
2025โ‚ฌ0.36 M-59.6%
2024โ‚ฌ0.9 M-64.26%
2023โ‚ฌ2.53 M-35.43%
2022โ‚ฌ3.92 M-74.81%
2021โ‚ฌ15.59 M-26.71%
2020โ‚ฌ21.27 M2750.05%
2019โ‚ฌ0.74 M-93.48%
2018โ‚ฌ11.44 M85.32%
2017โ‚ฌ6.17 M-25.24%
2016โ‚ฌ8.26 M-76.95%
2015โ‚ฌ35.83 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.21 Mโ‚ฌ15.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
โ‚ฌ12.23 Mโ‚ฌ47.82 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚ฌ14.35 Mโ‚ฌ59.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ12.39 Mโ‚ฌ17.27 M๐Ÿ‡บ๐Ÿ‡ธ USA